Nicox S.A.
$0.30+0.00%(+$0.00)
TickerSpark Score
61/100
53
Valuation
40
Profitability
100
Growth
52
Health
60
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NICXF research report →
52-Week Range30% of range
Low $0.24
Current $0.30
High $0.44
Companywww.nicox.com
Nicox S. A. operates as an ophthalmology company in France and internationally.
- CEO
- Gavin Spencer
- IPO
- 2010
- Employees
- 28
- HQ
- Biot, FR
Price Chart
+20.00% · this period
Valuation
- Market Cap
- $30.94M
- P/E
- -0.88
- P/S
- 4.01
- P/B
- 5.74
- EV/EBITDA
- -1.88
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 85.88%
- Op Margin
- -125.38%
- Net Margin
- -284.90%
- ROE
- -180.37%
- ROIC
- -45.98%
Growth & Income
- Revenue
- $16.76M · 113.32%
- Net Income
- $-2,412,095.7 · 89.23%
- EPS
- $-0.03 · 93.40%
- Op Income
- $6.63M
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $0.44
- 52W Low
- $0.24
- 50D MA
- $0.30
- 200D MA
- $0.29
- Beta
- 0.53
- Avg Volume
- 92.308
Get TickerSpark's AI analysis on NICXF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our NICXF Coverage
We haven't published any research on NICXF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate NICXF Report →Similar Companies
PRNAF+0.00%
Alterity Therapeutics Limited
$0.00
CLTEF-52.81%
Calliditas Therapeutics Ab
$0.33
BSEM-6.88%
BioStem Technologies, Inc.
$4.00
PHYOF+0.00%
IXICO plc
$0.07
ATGGF+0.00%
Actinogen Medical Limited
$0.00
RLFTY+0.00%
MindMaze Therapeutics Holding S.A. Sponsored ADR
$1.73
RLFTF-1.20%
MindMaze Therapeutics Holding S.A.
$0.53
PLNH+0.67%
Planet 13 Holdings Inc.
$0.13